The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
New Modalities for Challenging Targets in Drug Discovery
Open accessAbstract
Our ever‐increasing understanding of biological systems is providing a range of exciting novel biological targets, whose modulation may enable novel therapeutic options for many diseases. These targets include protein–protein and protein–nucleic acid interactions, which are, however, often refractory to classical small‐molecule approaches. Other types of molecules, or modalities, are therefore required to address these targets, which has led several academic research groups and pharmaceutical companies to increasingly use the concept of so‐called “new modalities”. This Review defines for the first time the scope of this term, which includes novel peptidic scaffolds, oligonucleotides, hybrids, molecular conjugates, as well as new uses of classical small molecules. We provide the most representative examples of these modalities to target large binding surface areas such as those found in protein–protein interactions and for biological processes at the center of cell regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide
Nielsen, P. E., Egholm, M., Berg, R. H., & Buchardt, O. (1991) · Science · doi:10.1126/science.1962210 · Cited by 3,332
RNA interference is mediated by 21- and 22-nucleotide RNAs
Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001) · Genes & Development · doi:10.1101/gad.862301 · Cited by 3,310
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Effective targeted gene ‘knockdown’ in zebrafish
Nasevicius, A., & Ekker, S. C. (2000) · Nature Genetics · doi:10.1038/79951 · Cited by 2,483
Kruger, K., Grabowski, P. J., Zaug, A. J., Sands, J., Gottschling, D. E., & Cech, T. R. (1982) · Cell · doi:10.1016/0092-8674(82)90414-7 · Cited by 2,331
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
Phthalimide conjugation as a strategy for in vivo target protein degradation
Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
Catalytic in vivo protein knockdown by small-molecule PROTACs
Bondeson, D. P., Mares, A., Smith, I. E. D., Ko, E., Campos, S., Miah, A. H., Mulholland, K. E., Routly, N., Buckley, D. L., Gustafson, J. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1858 · Cited by 1,356
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
Morphy, R., & Rankovic, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,209
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Lu, J., Qian, Y., Altieri, M., Dong, H., Wang, J., Raina, K., Hines, J., Winkler, J. D., Crew, A. P., Coleman, K., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.05.009 · Cited by 1,140
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Caplen, N. J., Parrish, S., Imani, F., Fire, A., & Morgan, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171251798 · Cited by 1,043
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Synthetic Multivalent Ligands as Probes of Signal Transduction
Kiessling, L. L., Gestwicki, J. E., & Strong, L. E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502794 · Cited by 864
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Raina, K., Lu, J., Qian, Y., Altieri, M., Gordon, D., Rossi, A. M. K., Wang, J., Chen, X., Dong, H., Siu, K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521738113 · Cited by 852
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Geary, R. S., Norris, D., Yu, R., & Bennett, C. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.008 · Cited by 845
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908201106 · Cited by 812
Craik, D. J., Daly, N. L., Bond, T., & Waine, C. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3383 · Cited by 809
Guichard, G., & Huc, I. (2011) · Chemical Communications · doi:10.1039/c1cc11137j · Cited by 769
Direct inhibition of the NOTCH transcription factor complex
Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
Heinis, C., Rutherford, T., Freund, S., & Winter, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.184 · Cited by 743
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733
Interconversion of single and double helices formed from synthetic molecular strands
Berl, V., Huc, I., Khoury, R. G., Krische, M. J., & Lehn, J.-M. (2000) · Nature · doi:10.1038/35037545 · Cited by 723
Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412070 · Cited by 717
Self-citationβ-Peptide Foldamers: Robust Helix Formation in a New Family of β-Amino Acid Oligomers
Appella, D. H., Christianson, L. A., Karle, I. L., Powell, D. R., & Gellman, S. H. (1996) · Journal of the American Chemical Society · doi:10.1021/ja963290l · Cited by 705
BAX activation is initiated at a novel interaction site
Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H.-C., Kim, H., Cheng, E. H.-Y., Tjandra, N., et al. (2008) · Nature · doi:10.1038/nature07396 · Cited by 700
Obika, S., Nanbu, D., Hari, Y., Andoh, J.-I., Morio, K.-I., Doi, T., & Imanishi, T. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01084-3 · Cited by 700
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Pandita, D., Madaan, K., Kumar, S., Poonia, N., & Lather, V. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.130965 · Cited by 679
Small‐Molecule PROTACS: New Approaches to Protein Degradation
Toure, M., & Crews, C. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201507978 · Cited by 674
Non-haemolytic β-amino-acid oligomers
Porter, E. A., Wang, X., Lee, H.-S., Weisblum, B., & Gellman, S. H. (2000) · Nature · doi:10.1038/35007145 · Cited by 671
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Srinivasarao, M., Galliford, C. V., & Low, P. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4519 · Cited by 671
Morpholino antisense oligomers: the case for an RNase H-independent structural type
Summerton, J. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00150-5 · Cited by 664
Chang, Y. S., Graves, B., Guerlavais, V., Tovar, C., Packman, K., To, K.-H., Olson, K. A., Kesavan, K., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 660
Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2682 · Cited by 646
Modular PROTAC design for the degradation of oncogenic BCR-ABL
Lai, A. C., Toure, M., Hellerschmied, D., Salami, J., Jaime‐Figueroa, S., Ko, E., Hines, J., & Crews, C. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201507634 · Cited by 618
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
Braasch, D. A., & Corey, D. R. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00058-2 · Cited by 605
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563
Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide
Bernal, F., Tyler, A. F., Korsmeyer, S. J., Walensky, L. D., & Verdine, G. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0693587 · Cited by 556
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
Macrocycles: lessons from the distant past, recent developments, and future directions
Yudin, A. K. (2015) · Chemical Science · doi:10.1039/c4sc03089c · Cited by 493
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Rodrik-Outmezguine, V. S., Okaniwa, M., Yao, Z., Novotny, C. J., McWhirter, C., Banaji, A., Won, H., Wong, W., Berger, M., de Stanchina, E., et al. (2016) · Nature · doi:10.1038/nature17963 · Cited by 479
Fc‐fusion proteins: new developments and future perspectives
Czajkowsky, D. M., Hu, J., Shao, Z., & Pleass, R. J. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201379 · Cited by 476
Macrocycles In New Drug Discovery
Mallinson, J., & Collins, I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.93 · Cited by 468
Alkyne-Tag Raman Imaging for Visualization of Mobile Small Molecules in Live Cells
Yamakoshi, H., Dodo, K., Palonpon, A., Ando, J., Fujita, K., Kawata, S., & Sodeoka, M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja308529n · Cited by 461
Hong, D., Kurzrock, R., Kim, Y., Woessner, R., Younes, A., Nemunaitis, J., Fowler, N., Zhou, T., Schmidt, J., Jo, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5272 · Cited by 445
Accurate de novo design of hyperstable constrained peptides
Bhardwaj, G., Mulligan, V. K., Bahl, C. D., Gilmore, J. M., Harvey, P. J., Cheneval, O., Buchko, G. W., Pulavarti, S. V. S. R. K., Kaas, Q., Eletsky, A., et al. (2016) · Nature · doi:10.1038/nature19791 · Cited by 440
The Medicinal Chemistry of Therapeutic Oligonucleotides
Wan, W. B., & Seth, P. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00551 · Cited by 429
Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells
Huang, Y., Shangguan, D., Liu, H., Phillips, J. A., Zhang, X., Chen, Y., & Tan, W. (2009) · ChemBioChem · doi:10.1002/cbic.200800805 · Cited by 422
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
Stewart, M. L., Fire, E., Keating, A. E., & Walensky, L. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.391 · Cited by 418
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418
Chen, H.-T., Neerman, M. F., Parrish, A. R., & Simanek, E. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048548j · Cited by 411
Membrane-permeable arginine-rich peptides and the translocation mechanisms
FUTAKI, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.009 · Cited by 406
Villar, E. A., Beglov, D., Chennamadhavuni, S., Porco, J. A., Kozakov, D., Vajda, S., & Whitty, A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1584 · Cited by 400
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
van der Meel, R., Vehmeijer, L. J. C., Kok, R. J., Storm, G., & van Gaal, E. V. B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.012 · Cited by 398
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., Li, J., Monbo, J., Zella, D., Tarasov, S. G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900947106 · Cited by 391
Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells
Muratovska, A., & Eccles, M. R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01505-9 · Cited by 390
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S. F., Kalgutkar, A. S., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.664 · Cited by 386
Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?
ECKSTEIN, F. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.117 · Cited by 382
Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin metathesis
Kim, Y.-W., Grossmann, T. N., & Verdine, G. L. (2011) · Nature Protocols · doi:10.1038/nprot.2011.324 · Cited by 376
Self-citationMoschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., & Lindsay, M. A. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070077d · Cited by 350
Manoharan, M. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00138-4 · Cited by 348
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
Bird, G. H., Madani, N., Perry, A. F., Princiotto, A. M., Supko, J. G., He, X., Gavathiotis, E., Sodroski, J. G., & Walensky, L. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002713107 · Cited by 347
De Novo Design of Antibacterial β-Peptides
Hamuro, Y., Schneider, J. P., & DeGrado, W. F. (1999) · Journal of the American Chemical Society · doi:10.1021/ja992728p · Cited by 345
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells
Lorenz, C., Hadwiger, P., John, M., Vornlocher, H.-P., & Unverzagt, C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.018 · Cited by 338
Targeted estrogen delivery reverses the metabolic syndrome
Finan, B., Yang, B., Ottaway, N., Stemmer, K., Müller, T. D., Yi, C.-X., Habegger, K., Schriever, S. C., García-Cáceres, C., Kabra, D. G., et al. (2012) · Nature Medicine · doi:10.1038/nm.3009 · Cited by 337
Probing the Helical Secondary Structure of Short‐Chain β‐Peptides
Seebàch, D., Ciceri, P. E., Overhand, M., Jaun, B., Rigo, D., Oberer, L., Hommel, U., Amstutz, R., & Widmer, H. (1996) · Helvetica Chimica Acta · doi:10.1002/hlca.19960790802 · Cited by 324
β-Hairpin Peptidomimetics: Design, Structures and Biological Activities
Robinson, J. A. (2008) · Accounts of Chemical Research · doi:10.1021/ar700259k · Cited by 321
Orner, B. P., Ernst, J. T., & Hamilton, A. D. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0025548 · Cited by 320
McCarthy, T. D., Karellas, P., Henderson, S. A., Giannis, M., O'Keefe, D. F., Heery, G., Paull, J. R. A., Matthews, B. R., & Holan, G. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050023q · Cited by 314
General approach to the synthesis of short .alpha.-helical peptides
Jackson, D. Y., King, D. S., Chmielewski, J., Singh, S., & Schultz, P. G. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00024a067 · Cited by 313
The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
Clark, R. J., Jensen, J., Nevin, S. T., Callaghan, B. P., Adams, D. J., & Craik, D. J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000620 · Cited by 313
Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of α-Tocopherol
Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., & Yokota, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.14 · Cited by 312
Timmerman, P., Beld, J., Puijk, W. C., & Meloen, R. H. (2005) · ChemBioChem · doi:10.1002/cbic.200400374 · Cited by 295
Hydrocarbon Stapled Peptides as Modulators of Biological Function
Cromm, P. M., Spiegel, J., & Grossmann, T. N. (2015) · ACS Chemical Biology · doi:10.1021/cb501020r · Cited by 290
Self-citationRNA interference using boranophosphate siRNAs: structure-activity relationships
Hall, A. H. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh936 · Cited by 285
Koller, E., Vincent, T. M., Chappell, A., De, S., Manoharan, M., & Bennett, C. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr089 · Cited by 281
Recent Advances in Developing Small Molecules Targeting RNA
Guan, L., & Disney, M. D. (2012) · ACS Chemical Biology · doi:10.1021/cb200447r · Cited by 280
Fu, D., Zhou, J., Zhu, W. S., Manley, P. W., Wang, Y. K., Hood, T., Wylie, A., & Xie, X. S. (2014) · Nature Chemistry · doi:10.1038/nchem.1961 · Cited by 275
Herbert, B.-S., Gellert, G. C., Hochreiter, A., Pongracz, K., Wright, W. E., Zielinska, D., Chin, A. C., Harley, C. B., Shay, J. W., & Gryaznov, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208760 · Cited by 268
Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin
Grossmann, T. N., Yeh, J. T.-H., Bowman, B. R., Chu, Q., Moellering, R. E., & Verdine, G. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208396109 · Cited by 268
Self-citationStimulated Raman scattering microscopy: an emerging tool for drug discovery
Tipping, W. J., Lee, M., Serrels, A., Brunton, V. G., & Hulme, A. N. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00693g · Cited by 266
Structure of the Stapled p53 Peptide Bound to Mdm2
Baek, S., Kutchukian, P. S., Verdine, G. L., Huber, R., Holak, T. A., Lee, K. W., & Popowicz, G. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2090367 · Cited by 259
Cell-penetrating peptides transport therapeutics into cells
Ramsey, J. D., & Flynn, N. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.003 · Cited by 256
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Maianti, J. P., McFedries, A., Foda, Z. H., Kleiner, R. E., Du, X. Q., Leissring, M. A., Tang, W.-J., Charron, M. J., Seeliger, M. A., Saghatelian, A., et al. (2014) · Nature · doi:10.1038/nature13297 · Cited by 254
Development of a Potent Bcl-xLAntagonist Based on α-Helix Mimicry
Kutzki, O., Park, H. S., Ernst, J. T., Orner, B. P., Yin, H., & Hamilton, A. D. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026861k · Cited by 253
Dado, G. P., & Gellman, S. H. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00082a029 · Cited by 248
Design and Structure of Stapled Peptides Binding to Estrogen Receptors
Phillips, C., Roberts, L. R., Schade, M., Bazin, R., Bent, A., Davies, N. L., Moore, R., Pannifer, A. D., Pickford, A. R., Prior, S. H., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202946k · Cited by 247
Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
Takada, K., Zhu, D., Bird, G. H., Sukhdeo, K., Zhao, J.-J., Mani, M., Lemieux, M., Carrasco, D. E., Ryan, J., Horst, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003808 · Cited by 245
In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide
Ji, Y., Majumder, S., Millard, M., Borra, R., Bi, T., Elnagar, A. Y., Neamati, N., Shekhtman, A., & Camarero, J. A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405108p · Cited by 233
Wong, C. T. T., Rowlands, D. K., Wong, C., Lo, T. W. C., Nguyen, G. K. T., Li, H., & Tam, J. P. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201200984 · Cited by 229
Selection-Based Discovery of Druglike Macrocyclic Peptides
Passioura, T., Katoh, T., Goto, Y., & Suga, H. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035456 · Cited by 222
An Overview of Sugar‐Modified Oligonucleotides for Antisense Therapeutics
Prakash, T. P. (2011) · Chemistry & Biodiversity · doi:10.1002/cbdv.201100081 · Cited by 218
Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices
Bird, G. H., Mazzola, E., Opoku-Nsiah, K., Lammert, M. A., Godes, M., Neuberg, D. S., & Walensky, L. D. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2153 · Cited by 215
Zhu, G., Niu, G., & Chen, X. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00291 · Cited by 213
Ingallinella, P., Bianchi, E., Ladwa, N. A., Wang, Y.-J., Hrin, R., Veneziano, M., Bonelli, F., Ketas, T. J., Moore, J. P., Miller, M. D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901007106 · Cited by 212
Nontoxic Membrane‐Active Antimicrobial Arylamide Oligomers
Liu, D., Choi, S., Chen, B., Doerksen, R. J., Clements, D. J., Winkler, J. D., Klein, M. L., & DeGrado, W. F. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200352791 · Cited by 211
Exploring Chemical Modifications for siRNA Therapeutics: A Structural and Functional Outlook
Shukla, S., Sumaria, C. S., & Pradeepkumar, P. I. (2010) · ChemMedChem · doi:10.1002/cmdc.200900444 · Cited by 210
Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products
Hewitt, W. M., Leung, S. S. F., Pye, C. R., Ponkey, A. R., Bednarek, M., Jacobson, M. P., & Lokey, R. S. (2015) · Journal of the American Chemical Society · doi:10.1021/ja508766b · Cited by 210
Structural and conformational determinants of macrocycle cell permeability
Over, B., Matsson, P., Tyrchan, C., Artursson, P., Doak, B. C., Foley, M. A., Hilgendorf, C., Johnston, S. E., Lee, M. D., Lewis, R. J., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2203 · Cited by 209
Structure-Based Design of an Indolicidin Peptide Analogue with Increased Protease Stability,
Rozek, A., Powers, J.-P. S., Friedrich, C. L., & Hancock, R. E. W. (2003) · Biochemistry · doi:10.1021/bi035643g · Cited by 206
A versatile synthetic dimerizer for the regulation of protein–protein interactions
Amara, J. F., Clackson, T., Rivera, V. M., Guo, T., Keenan, T., Natesan, S., Pollock, R., Yang, W., Courage, N. L., Holt, D. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10618 · Cited by 206
Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates
Shukla, R., Thomas, T. P., Peters, J., Kotlyar, A., Myc, A., & Baker, Jr. (2005) · Chemical Communications · doi:10.1039/b507350b · Cited by 205
Antisense oligonucleotides: modifications and clinical trials
Sharma, V. K., Sharma, R. K., & Singh, S. K. (2014) · Med. Chem. Commun. · doi:10.1039/c4md00184b · Cited by 204
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds
Chan, L. Y., Gunasekera, S., Henriques, S. T., Worth, N. F., Le, S.-J., Clark, R. J., Campbell, J. H., Craik, D. J., & Daly, N. L. (2011) · Blood · doi:10.1182/blood-2011-06-359141 · Cited by 203
Comprehensive analysis of loops at protein-protein interfaces for macrocycle design
Gavenonis, J., Sheneman, B. A., Siegert, T. R., Eshelman, M. R., & Kritzer, J. A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1580 · Cited by 198
Tuning the Biological Activity Profile of Antibacterial Polymers via Subunit Substitution Pattern
Liu, R., Chen, X., Chakraborty, S., Lemke, J. J., Hayouka, Z., Chow, C., Welch, R. A., Weisblum, B., Masters, K. S., & Gellman, S. H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja500367u · Cited by 193
Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic Inhibitors
Jochim, A. L., & Arora, P. S. (2010) · ACS Chemical Biology · doi:10.1021/cb1001747 · Cited by 191
Finan, B., Clemmensen, C., Zhu, Z., Stemmer, K., Gauthier, K., Müller, L., De Angelis, M., Moreth, K., Neff, F., Perez-Tilve, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.014 · Cited by 191
Morpholino antisense oligonucleotides: tools for investigating vertebrate development.
Corey, D. R., & Abrams, J. (2001) · Genome biology · doi:10.1186/gb-2001-2-5-reviews1015 · Cited by 188
Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified
Beck, J. G., Chatterjee, J., Laufer, B., Kiran, M. U., Frank, A. O., Neubauer, S., Ovadia, O., Greenberg, S., Gilon, C., Hoffman, A., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303200d · Cited by 187
Miranda, E., Nordgren, I. K., Male, A. L., Lawrence, C. E., Hoakwie, F., Cuda, F., Court, W., Fox, K. R., Townsend, P. A., Packham, G. K., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402993u · Cited by 185
Manoharan, M. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760070849 · Cited by 185
Nontoxic Membrane‐Active Antimicrobial Arylamide Oligomers
Liu, D., Choi, S., Chen, B., Doerksen, R. J., Clements, D. J., Winkler, J. D., Klein, M. L., & DeGrado, W. F. (2004) · Angewandte Chemie · doi:10.1002/ange.200352791 · Cited by 184
Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease Target
Angelini, A., Cendron, L., Chen, S., Touati, J., Winter, G., Zanotti, G., & Heinis, C. (2012) · ACS Chemical Biology · doi:10.1021/cb200478t · Cited by 182
Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition
(2007) · CRC Press eBooks · doi:10.1201/9780849387951 · Cited by 181
Fasan, R., Dias, R. L. A., Moehle, K., Zerbe, O., Vrijbloed, J. W., Obrecht, D., & Robinson, J. A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353242 · Cited by 180
Ahlbach, C. L., Lexa, K. W., Bockus, A. T., Chen, V., Crews, P., Jacobson, M. P., & Lokey, R. S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.78 · Cited by 178
A General Method for Constraining Short Peptides to an α-Helical Conformation
Phelan, J. C., Skelton, N. J., Braisted, A. C., & McDowell, R. S. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9611654 · Cited by 177
Price, C. F., Tyssen, D., Sonza, S., Davie, A., Evans, S., Lewis, G. R., Xia, S., Spelman, T., Hodsman, P., Moench, T. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024095 · Cited by 173
Plamboeck, A., Holst, J. J., Carr, R. D., & Deacon, C. F. (2005) · Diabetologia · doi:10.1007/s00125-005-1847-7 · Cited by 173
Identification and Characterization of a New Family of Cell-penetrating Peptides
Cascales, L., Henriques, S. T., Kerr, M. C., Huang, Y.-H., Sweet, M. J., Daly, N. L., & Craik, D. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264424 · Cited by 172
Clark, R. J., Daly, N. L., & Craik, D. J. (2006) · Biochemical Journal · doi:10.1042/bj20051691 · Cited by 172
Macrocyclic and Helical Oligoamides as a New Class of G-Quadruplex Ligands
Shirude, P. S., Gillies, E. R., Ladame, S., Godde, F., Shin-ya, K., Huc, I., & Balasubramanian, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073775h · Cited by 171
Therapeutic Potential of Foldamers: From Chemical Biology Tools To Drug Candidates?
Gopalakrishnan, R., Frolov, A. I., Knerr, L., Drury, W. J., & Valeur, E. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00376 · Cited by 171
Self-citationMolecular complexity and fragment-based drug discovery: ten years on
Leach, A. R., & Hann, M. M. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.008 · Cited by 169
Cabezas, E., & Satterthwait, A. C. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983212t · Cited by 168
Stitched α-Helical Peptides via Bis Ring-Closing Metathesis
Hilinski, G. J., Kim, Y.-W., Hong, J., Kutchukian, P. S., Crenshaw, C. M., Berkovitch, S. S., Chang, A., Ham, S., & Verdine, G. L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505141j · Cited by 164
Vergunst, C. E., Gerlag, D. M., Dinant, H., Schulz, L., Vinkenoog, M., Smeets, T. J. M., Sanders, M. E., Reedquist, K. A., & Tak, P. P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem222 · Cited by 163
Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices
Leshchiner, E. S., Parkhitko, A. A., Bird, G. H., Luccarelli, J., Bellairs, J. A., Escudero, S., Opoku-Nsiah, K., Godes, M., Perrimon, N., & Walensky, L. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413185112 · Cited by 162
Probing the Structural Requirements of Peptoids That Inhibit HDM2−p53 Interactions
Hara, T. J., Durell, S. R., Myers, M. C., & Appella, D. H. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056344c · Cited by 161
Hamuro, Y., Geib, S. J., & Hamilton, A. D. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199404461 · Cited by 161
Boersma, M., Haase, H. S., Peterson‐Kaufman, K. J., Lee, E. F., Clarke, O. B., Colman, P. M., Smith, B. J., Horne, W. S., Fairlie, W. D., & Gellman, S. H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207148m · Cited by 157
Cytotoxicity of Polypropylenimine Dendrimer Conjugates on Cultured Endothelial Cells
Stasko, N., Johnson, C. B., Schoenfisch, M. H., Johnson, T. A., & Holmuhamedov, E. (2007) · Biomacromolecules · doi:10.1021/bm7008203 · Cited by 156
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
Krieg, A. Μ. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00147-5 · Cited by 154
Peptide‐mediated targeted drug delivery
Majumdar, S., & Siahaan, T. J. (2010) · Medicinal Research Reviews · doi:10.1002/med.20225 · Cited by 152
A biomimetic approach for enhancing the in vivo half-life of peptides
Penchala, S., Miller, M. R., Pal, A., Dong, J., Madadi, N. R., Xie, J., Joo, H., Tsai, J. W., Batoon, P. H. M., Samoshin, V. V., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1907 · Cited by 152
Wang, C. K. L., Gruber, C. W., Čemažar, M., Siatskas, C., Tagore, P. R. N., Payne, N. L., Sun, G., Wang, S., Bernard, C. C. A., & Craik, D. J. (2013) · ACS Chemical Biology · doi:10.1021/cb400548s · Cited by 148
Bockus, A. T., Lexa, K. W., Pye, C. R., Kalgutkar, A. S. S., Gardner, J. W., Hund, K. C. R., Hewitt, W. M., Schwochert, J. A., Glassey, E., Price, D. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00128 · Cited by 147
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis
Thell, K., Hellinger, R., Sahin, E., Michenthaler, P., Gold-Binder, M., Haider, T. T., Kuttke, M., Liutkevičiūtė, Z., Göransson, U., Gründemann, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519960113 · Cited by 147
Mechanism-Based Inhibition of Sir2 Deacetylases by Thioacetyl-Lysine Peptide
Smith, B. C., & Denu, J. M. (2007) · Biochemistry · doi:10.1021/bi7013294 · Cited by 145
Glas, A., Bier, D., Hahne, G., Rademacher, C., Ottmann, C., & Grossmann, T. N. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310082 · Cited by 145
Self-citationHu, K., Geng, H. R., Zhang, Q., Liu, Q., Xie, M., Sun, C., Li, W., Lin, H., Jiang, F., Wang, T., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602806 · Cited by 142
Yin, H., Moulton, H. M., Betts, C., Seow, Y., Boutilier, J. K., Iverson, P. L., & Wood, M. J. A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp395 · Cited by 137
Okamoto, T., Zobel, K., Fedorova, A., Quan, C., Yang, H., Fairbrother, W. J., Huang, D. C. S., Smith, B. J., Deshayes, K., & Czabotar, P. E. (2013) · ACS Chemical Biology · doi:10.1021/cb3005403 · Cited by 136
Mimicking Helical Antibacterial Peptides with Nonpeptidic Folding Oligomers
Violette, A., Fournel, S., Lamour, K., Chaloin, O., Frisch, B., Briand, J., Monteil, H., & Guichard, G. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.03.009 · Cited by 135
The Medicinal Chemistry of Peptides
NESTOR, J. J. J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789712907 · Cited by 134
Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis
Alam, M. R., Dixit, V., Kang, H. M., Li, Z., Chen, X. S., Trejo, J., Fisher, M. H., & Juliano, R. L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn115 · Cited by 133
Rand, A. C., Leung, S. S. F., Eng, H. F., Rotter, C. J., Sharma, R., Kalgutkar, A. S. S., Zhang, Y., Varma, M. V. S., Farley, K. A., Khunte, B., et al. (2012) · MedChemComm · doi:10.1039/c2md20203d · Cited by 132
Wan, W. B., Migawa, M. T., Vasquez, G., Murray, H. M., Nichols, J. G., Gaus, H. J., Berdeja, A., Lee, S. S., Hart, C. E., Lima, W. F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1115 · Cited by 132
Rational Design of Topographical Helix Mimics as Potent Inhibitors of Protein–Protein Interactions
Lao, B. B., Drew, K., Guarracino, D. A., Brewer, T. F., Heindel, D. W., Bonneau, R., & Arora, P. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502310r · Cited by 132
Cell-Permeable Bicyclic Peptide Inhibitors against Intracellular Proteins
Lian, W., Jiang, B., Qian, Z., & Pei, D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503710n · Cited by 130
Synthetische multivalente Liganden als Sonden für die Signaltransduktion
Kiessling, L. L., Gestwicki, J. E., & Strong, L. E. (2006) · Angewandte Chemie · doi:10.1002/ange.200502794 · Cited by 129
Lian, W., Upadhyaya, P., Rhodes, C. A., Liu, Y., & Pei, D. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405106u · Cited by 129
Double Strain‐Promoted Macrocyclization for the Rapid Selection of Cell‐Active Stapled Peptides
Lau, Y. H., Wu, Y., Rossmann, M., Tan, B. X., de Andrade, P., Tan, Y. S., Verma, C. S., McKenzie, G. J., Venkitaraman, A. R., Hyvönen, M., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508416 · Cited by 128
Evolution of cyclic peptide protease inhibitors
Young, T. S., Young, D. D., Ahmad, I., Louis, J. M., Benkovic, S. J., & Schultz, P. G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108045108 · Cited by 128
Illien, F., Rodríguez, N., Amoura, M., Joliot, A., Manjula, P., Cribier, S., Burlina, F., & Sagan, S. (2016) · Scientific Reports · doi:10.1038/srep36938 · Cited by 128
Multivalent Cyclic RGD Conjugates for Targeted Delivery of Small Interfering RNA
Alam, M. R., Ming, X., Fisher, M. H., Lackey, J. G., Rajeev, K. G., Manoharan, M., & Juliano, R. L. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200235q · Cited by 127
Oral Delivery of Antisense Oligonucleotides in Man
Tillman, L., Geary, R. S., & Hardee, G. E. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21084 · Cited by 127
Backbone modification of a polypeptide drug alters duration of action in vivo
Cheloha, R. W., Maeda, A., Dean, T., Gardella, T. J., & Gellman, S. H. (2014) · Nature Biotechnology · doi:10.1038/nbt.2920 · Cited by 125
Gault, V. A., Bhat, V. K., Irwin, N., & Flatt, P. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512046 · Cited by 123
Oka, N., Yamamoto, M., Sato, T., & Wada, T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805780u · Cited by 123
Trinh, T. B., Upadhyaya, P., Qian, Z., & Pei, D. (2015) · ACS Combinatorial Science · doi:10.1021/acscombsci.5b00164 · Cited by 123
Cell-penetrating-peptide-based delivery of oligonucleotides: an overview
Abes, R., Arzumanov, A. A., Moulton, H. M., Abes, S., Ivanova, G. D., Iversen, P. L., Gait, M. J., & Lebleu, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350775 · Cited by 122
Artificial human Met agonists based on macrocycle scaffolds
Ito, K., Sakai, K., Suzuki, Y., Ozawa, N., Hatta, T., Natsume, T., Matsumoto, K., & Suga, H. (2015) · Nature Communications · doi:10.1038/ncomms7373 · Cited by 122
Hamzah, J., Kotamraju, V. R., Seo, J. W., Agemy, L., Fogal, V., Mahakian, L. M., Peters, D., Roth, L., Gagnon, M.-H., Ferrara, K. W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104540108 · Cited by 122
Ribosomal Synthesis of Bicyclic Peptides via Two Orthogonal Inter-Side-Chain Reactions
Sako, Y., Morimoto, J., Murakami, H., & Suga, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800953c · Cited by 122
Tools and rules for macrocycles
Heinis, C. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1605 · Cited by 122
Dirin, M., & Winkler, J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.774366 · Cited by 120
Nakagawa, O., Ming, X., Huang, L., & Juliano, R. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102635c · Cited by 120
Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
Dohmen, C., Fröhlich, T., Lächelt, U., Röhl, I., Vornlocher, H., Hadwiger, P., & Wagner, E. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2011.10 · Cited by 117
Investigational Antimicrobial Agents of 2013
Pucci, M. J., & Bush, K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00033-13 · Cited by 113
Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways
Contreras, J., Elnagar, A. Y., Hamm‐Alvarez, S. F., & Camarero, J. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.030 · Cited by 112
Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
Moreno, P. M. D., & Pêgo, A. P. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00087 · Cited by 111
Nano Secondary Ion Mass Spectrometry Imaging of Dopamine Distribution Across Nanometer Vesicles
Lovrić, J., Dunevall, J., Larsson, A. C., Ren, L., Andersson, S., Meibom, A., Malmberg, P., Kurczy, M. E., & Ewing, A. G. (2016) · ACS Nano · doi:10.1021/acsnano.6b07233 · Cited by 109
Chorev, M., Roubini, E., McKee, R. L., Gibbons, S. W., Goldman, M. E., Caulfield, M. P., & Rosenblatt, M. (1991) · Biochemistry · doi:10.1021/bi00238a022 · Cited by 107
Bijsterbosch, M. K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.14.2717 · Cited by 107
Molecular Profiling of Heart Endothelial Cells
Zhang, L., Hoffman, J. A., & Ruoslahti, E. I. (2005) · Circulation · doi:10.1161/circulationaha.104.529537 · Cited by 107
Çirak, S., Feng, L., Anthony, K., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.248 · Cited by 107
Steffens, R., & Leumann, C. J. (1997) · Journal of the American Chemical Society · doi:10.1021/ja972597x · Cited by 103
Auzzas, L., Zanardi, F., Battistini, L., et al. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790936301 · Cited by 103
Eliasen, R., Daly, N. L., Wulff, B. S., Andresen, T. L., Conde‐Frieboes, K. W., & Craik, D. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.395442 · Cited by 101
Tannert, R., Milroy, L. ‐., Ellinger, B., Hu, T., Arndt, H., & Waldmann, H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9095126 · Cited by 100
Self-citation
Cited by
GuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848
Late-stage C–H functionalization offers new opportunities in drug discovery
Guillemard, L., Kaplaneris, N., Ackermann, L., & Johansson, M. J. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00300-6 · Cited by 837
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Pettersson, M., & Crews, C. M. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2019.01.002 · Cited by 800
Photocatalytic Late-Stage C–H Functionalization
Bellotti, P., Huang, H.-M., Faber, T., & Glorius, F. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00478 · Cited by 623
Metadata
- Authors
- Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2017-07-24
- Volume
- 56
- Issue
- 35
- Pages
- 10294-10323
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2586869611
- Cited by
- 382
- References
- 326
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.